Institut Galien Paris-Saclay

The Institut Galien Paris-Saclay (UMR CNRS 8612), founded in 1986, develops micro- and nanotechnologies applied to drug delivery and diagnostics in the field of healthcare. A distinctive feature of the institute is its multidisciplinary approach, bringing together researchers and teacher-researchers from diverse fields such as chemistry, physical chemistry, pharmaceutics, analytical chemistry, and biology.

Research at the institute is structured around four major scientific challenges:

• Overcoming physiological barriers
• Designing intelligent, programmable, activatable, and biocompatible materials
• Developing predictive models for the formation of novel systems and their transport across biological barriers (tissue, cellular, and subcellular)
• Applying chemistry, physical chemistry, and formulation to diagnostics and imaging

To address these challenges, the Institut Galien Paris-Saclay is supported by four dedicated technological platforms: nano-object characterization, biology, analytical sciences, and biophysics & instrumentation. The institute’s international reputation is reflected in the high number of PhD students and postdoctoral researchers it attracts from around the world.

Our unit is home to 4 members of the Institut Universitaire de France, 1 ERC grantee, 5 members of the French National Academy of Pharmacy, and 1 member of the French Academy of Sciences.

We recently relocated to the Henri Moissan site on the Moulon plateau in Orsay, a new facility that brings us closer to many other research units. This move strengthens our contribution to the global reputation of Université Paris-Saclay and the CNRS in the field of pharmaceutical sciences.